Charis Teh

Charis Teh

Walter and Eliza Hall Institute of Medical Research - Parkville / Australia
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4392766
person_outline Charis Teh's MOST POPULAR ARTICLES
1-) Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemiaP Blombery, MA Anderson, J Gong, R Thijssen, RW Birkinshaw, ...Cancer discovery 9 (3), 342-353, 20192932019
2-) CIS is a potent checkpoint in NK cell–mediated tumor immunityRB Delconte, TB Kolesnik, LF Dagley, J Rautela, W Shi, EM Putz, ...Nature Immunology 17 (7), 816-824, 20162652016
3-) Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaR Agarwal, YC Chan, CS Tam, T Hunter, D Vassiliadis, CE Teh, ...Nature Medicine 25 (1), 119-129, 20191292019
4-) ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytesM Yabas, CE Teh, S Frankenreiter, D Lal, CM Roots, B Whittle, ...Nature immunology 12 (5), 441-449, 20111472011
5-) A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2–positive metastatic breast cancerSW Lok, JR Whittle, F Vaillant, CE Teh, LL Lo, AN Policheni, ART Bergin, ...Cancer discovery 9 (3), 354-369, 20191372019